Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02724800 · ClinicalTrials.gov registry record · NA
Implementation of Brief Insomnia Treatments - Clinical Trial
A NA study, sponsored by VA Pittsburgh Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT02724800: Completed NA study, sponsored by VA Pittsburgh Healthcare System.
NCT02724800 is a NA study that has completed, run by VA Pittsburgh Healthcare System. The registered enrollment target is 92 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02724800, a NA study, has completed, sponsored by VA Pittsburgh Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
The purpose of this study is to directly compare the effectiveness of two interventions for insomnia: Brief Behavioral Treatment for Insomnia (BBTI) vs. Cognitive Behavioral Therapy for Insomnia (CBTI).
Primary Outcome
Insomnia Severity Index (ISI) 0-28; 0-7 (no symptoms), 8-14 (sub-threshold symptoms), 15-21 (moderately severe), 22-28 (severe) high scores indicate worse outcome/greater severity
Interventions
- BEHAVIORAL CBTI
- BEHAVIORAL BBTI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-03 |
| Phase | NA |
What the finished NCT02724800 record still lists
NCT02724800 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which CBTI is the first listed.
NCT02724800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02724800 about?
NCT02724800 is a clinical study titled "Implementation of Brief Insomnia Treatments - Clinical Trial". The purpose of this study is to directly compare the effectiveness of two interventions for insomnia: Brief Behavioral Treatment for Insomnia (BBTI) vs. Cognitive Behavioral Therapy for Insomnia (CBTI).
What is the current status of trial NCT02724800?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2016-04. Estimated completion is 2020-03.
What interventions are being tested in trial NCT02724800?
The interventions under investigation include: CBTI (BEHAVIORAL), BBTI (BEHAVIORAL).
Who is sponsoring clinical trial NCT02724800?
This trial is sponsored by VA Pittsburgh Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02724800's enrollment target sits among peer trials
92 937th of 2000 higher than 1,062 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia